Clinical Trials Browser

Hemangiosarcoma

Ovarian Neoplasms

Recurrent High Grade Uterine Cancer

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Urinary Bladder Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms, Recurrence

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Esophageal Neoplasms, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Triple Negative Breast Neoplasms

Esophageal Neoplasms

Breast Neoplasms

Neoplasms, Unknown Primary

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms, Neoplasms

Breast Neoplasms

Head and Neck Neoplasms

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Unspecified Adult Solid Tumor, Protocol Specific

Prostatic Neoplasms

Urinary Bladder Neoplasms, Neoplasms

Breast Neoplasms

Stomach Neoplasms

Clinical Trials

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

PELICAN

SMMART Adaptive Clinical Treatment (ACT) Trial

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

CRATER

Neoadjuvant Immunotherapy to ESCC

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)

A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

TRIUMPH

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.